Search all trials

Find therapies in clinical trials near you – page 15

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 968
countries: 28
conditions: 2 103

3 968 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Factor VIII deficiency

Recruiting

Registered drugNo placebo

A Phase III study of NXT007 compared with simoctocog alfa prophylaxis in patients with Hemophilia A without inhibitors

Registered drugNo placebo

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Ro7589655

Contact Research Centre

Myelofibrosis+1

Recruiting

Registered drug

Study of pelabresib (DAK539) plus ruxolitinib versus placebo plus ruxolitinib in adult patients with myelofibrosis who are JAK‑inhibitor‑naive

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Ruxolitinib

Contact Research Centre

Non-Hodgkin's lymphoma

Recruiting

Registered drugNo placebo

Study of MK-1045 alone or with Tocilizumab in patients with Non‑Hodgkin Lymphoma to evaluate safety and efficacy

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Tocilizumab

Contact Research Centre

Rheumatoid arthritis

Recruiting

Investigational

Long‑Term Safety and Efficacy of RO7790121 in Adults with Moderate to Severe Rheumatoid Arthritis: Extension Study

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Ro7790121

Contact Research Centre

Dementia of the Alzheimer's type with delusions

Recruiting

InvestigationalNo placebo

Long‑Term Safety and Tolerability of Oral Fesoterodine in Adults with Hallucinations and Delusions Due to Alzheimer’s Disease Psychosis

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:5-[(1R,5R)-3-AZABICYCLO[3.1.0]HEXAN-1-YL]-3-METHYL-1,2,4-OXADIAZOLE

Contact Research Centre

Crohn's disease

Recruiting

Registered drugNo placebo

A Phase 3b Study of Guselkumab Compared with Risankizumab in Adults with Moderately to Severely Active Crohn’s Disease

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Guselkumab

Contact Research Centre

Asthma

Recruiting

Investigational

Efficacy and safety of GB-0895 as adjunctive therapy in adults and adolescents with severe uncontrolled asthma (randomized, placebo‑controlled)

Investigational

Italy

Participants:0–17 years · 18–64 years · 65+ years

Contact Research Centre

Neoplasm

Recruiting

InvestigationalNo placebo

Safety and Efficacy of Ifinatamab Deruxtecan in Pediatric Patients Under 18 With Relapsed or Refractory Solid Tumors

InvestigationalNo placebo

Italy

Participants:0–17 years
Substances:Ifinatamab Deruxtecan

Contact Research Centre

Plasma cell myeloma refractory

Recruiting

InvestigationalNo placebo

Cemsidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years

Contact Research Centre

Non-small cell lung cancer stage III

Recruiting

Registered drugNo placebo

Pumitamig Versus Durvalumab in Patients With Unresectable Stage III Non-Small Cell Lung Cancer Without Progression After Chemoradiation

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Durvalumab

Contact Research Centre

Non-small cell lung cancer stage IV

Recruiting

Registered drug

EIK1001, Pembrolizumab, and Chemotherapy for Stage 4 Non-Small Cell Lung Cancer in Patients with Stage 4 Non-Small Cell Lung Cancer

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Long-Term Safety and Efficacy of KL1333 in Adults with Primary Mitochondrial Disease

Recruiting

InvestigationalNo placebo

Long-Term Safety and Efficacy of KL1333 in Adults with Primary Mitochondrial Disease

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:2-Isopropyl-3H-Naphtho(1,2-D)Imidazole-4,5-Dione

Contact Research Centre

Find therapies in clinical trials near you – page 15

2 209 trials match your criteria

Factor VIII deficiency

A Phase III study of NXT007 compared with simoctocog alfa prophylaxis in patients with Hemophilia A without inhibitors

Myelofibrosis+1

Study of pelabresib (DAK539) plus ruxolitinib versus placebo plus ruxolitinib in adult patients with myelofibrosis who are JAK‑inhibitor‑naive

Non-Hodgkin's lymphoma

Study of MK-1045 alone or with Tocilizumab in patients with Non‑Hodgkin Lymphoma to evaluate safety and efficacy

Rheumatoid arthritis

Long‑Term Safety and Efficacy of RO7790121 in Adults with Moderate to Severe Rheumatoid Arthritis: Extension Study

Dementia of the Alzheimer's type with delusions

Long‑Term Safety and Tolerability of Oral Fesoterodine in Adults with Hallucinations and Delusions Due to Alzheimer’s Disease Psychosis

Crohn's disease

A Phase 3b Study of Guselkumab Compared with Risankizumab in Adults with Moderately to Severely Active Crohn’s Disease

Asthma

Efficacy and safety of GB-0895 as adjunctive therapy in adults and adolescents with severe uncontrolled asthma (randomized, placebo‑controlled)

Neoplasm

Safety and Efficacy of Ifinatamab Deruxtecan in Pediatric Patients Under 18 With Relapsed or Refractory Solid Tumors

Plasma cell myeloma refractory

Cemsidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma

Non-small cell lung cancer stage III

Pumitamig Versus Durvalumab in Patients With Unresectable Stage III Non-Small Cell Lung Cancer Without Progression After Chemoradiation

Non-small cell lung cancer stage IV

EIK1001, Pembrolizumab, and Chemotherapy for Stage 4 Non-Small Cell Lung Cancer in Patients with Stage 4 Non-Small Cell Lung Cancer

Long-Term Safety and Efficacy of KL1333 in Adults with Primary Mitochondrial Disease

Long-Term Safety and Efficacy of KL1333 in Adults with Primary Mitochondrial Disease

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.